Top 50 Biotech VC Funds & Investors in Middle East (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Trendlines Group
VC Fund
|
17 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Pontifax
VC Fund
|
16 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $4M–$104M |
|
Israel Innovation Authority
VC Fund
|
12 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Medical Device | $100k–$6M |
|
OurCrowd
VC Fund
|
10 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $612k–$70M |
|
TRANGELS
VC Fund
|
10 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Software, Information Technology, Biotechnology | $24k–$1.4M |
|
aMoon Fund
VC Fund
|
7 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
OrbiMed
VC Fund
|
7 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Docor International Management
VC Fund
|
6 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
Arkin Holdings
VC Fund
|
6 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$95M |
|
HBL Hadasit Bio Holdings
VC Fund
|
5 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
ZORA Ventures
VC Fund
|
5 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Health Care, Biotechnology, Internet | $1M–$7M |
|
Diffusion Capital Partners
VC Fund
|
4 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $439k–$2.7M |
|
Grove Ventures
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
iAngels
VC Fund
|
4 | United States, Israel, United Kingdom | Seed, Series A | Software, Artificial Intelligence, Financial Services | $1M–$22M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
4 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
Sapir Venture Partners
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$40M |
|
Clal Biotechnology Industries
VC Fund
|
4 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
|
New York Ventures
VC Fund
|
4 | United States, Canada, Israel | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.5M–$53M |
|
Takeda Ventures
VC Fund
|
4 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Welltech Ventures
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed | mHealth, Health Care, Biotechnology | $1.9M–$19M |
|
Istcapital
VC Fund
|
3 | Turkey, United States | Seed, Series A | Biotechnology, Beauty, Gaming | $1M–$2.5M |
|
Milk & Honey Ventures
VC Fund
|
3 | Israel | Pre-Seed, Seed, Series A | Biotechnology, Food and Beverage, Nutrition | $1.8M–$1.9M |
|
Consensus Business Group
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Series A | Health Care, Medical Device, Medical | $1M–$10M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Neo Ventures
VC Fund
|
3 | Israel, United Kingdom, Estonia | Seed, Series A | Software, Artificial Intelligence, Aerospace | |
|
GlenRock Israel
VC Fund
|
3 | Israel, United States | Seed, Series B, Series A | Software, Cyber Security, Health Care | $100k–$19M |
|
Binder & Partners Ventures
VC Fund
|
3 | Israel, France, United States | Seed, Pre-Seed, Series A | Software, Information Technology, Computer | $8M–$14M |
|
EIT Food
VC Fund
|
3 | United Kingdom, Israel, Germany | Grant, Seed | Food and Beverage, Biotechnology, Food Processing | $30k–$11M |
|
Millenium Food-Tech
VC Fund
|
3 | Israel | Seed, Series A, Convertible Note | Food and Beverage, Manufacturing, Retail | $2.5M–$15M |
|
Pitango VC
VC Fund
|
3 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
Nevateam Partners
VC Fund
|
3 | Israel | Seed, Series A | AgTech, SaaS, Farming | $5M–$10M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
SciSparc
VC Fund
|
3 | Israel | Corporate Round | Pharmaceutical, Cannabis, Biopharma | $400k–$700k |
|
Egypt Ventures
VC Fund
|
3 | Egypt, Ireland, United States | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $28k–$3M |
|
Cancer Focus Fund
VC Fund
|
3 | Israel, United States, Germany | Series A, Seed | Biotechnology, Medical, Health Care | $5.4M–$28M |
|
Siddhi Capital
VC Fund
|
3 | United States, Israel, Canada | Seed, Series A, Series B | Food and Beverage, Biotechnology, Nutrition | $1.7M–$106M |
|
FutuRx
VC Fund
|
3 | Israel | Seed | Biotechnology, Life Science, Biopharma | |
|
Office of the Chief Scientist
VC Fund
|
3 | Israel | Seed | Health Care, Biotechnology, Hardware | $500k–$1M |
|
Kinisis Ventures
VC Fund
|
3 | Cyprus, United States, United Kingdom | Seed, Series A | Manufacturing, Biotechnology, Internet of Things | $1.1M–$2M |
|
fresh.fund
VC Fund
|
3 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $120k–$21M |
|
Accelmed
VC Fund
|
3 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
ACT Venture Partners
VC Fund
|
3 | Turkey, United States, United Kingdom | Seed, Series A, Convertible Note | Artificial Intelligence, Software, Biotechnology | $345k–$9M |
|
Agriline
VC Fund
|
2 | Israel | Seed, Series A | Health Care, Medical Device, Medical | |
|
BRM Capital
VC Fund
|
2 | United States, Israel | Series B, Series A | Software, Information Technology, Internet | |
|
Triventures
VC Fund
|
2 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | |
|
OTV
VC Fund
|
2 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | |
|
NextLeap Ventures
VC Fund
|
2 | Israel, United States | Seed, Series A | Software, Machine Learning, Health Care | |
|
LoftyInc Capital Management
VC Fund
|
2 | United States, Nigeria, Egypt | Seed, Pre-Seed, Series A | FinTech, Financial Services, Software | |
|
Chartered Opus
VC Fund
|
2 | Israel | Series A | Wellness, Biotechnology, Manufacturing | |
| Access all 50 VC funds in Middle East Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 106
- Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 141
- Round size: Seed $590k–$6M; Grant $100k–$3.5M; Pre-Seed $150k–$2.5M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Q-Factor —
- Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 261
- Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
- PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $52k–$1.4M; Angel $24k–$500k; Pre-Seed $29k–$400k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- PackUpp — PackUpp is a new generation on-demand “Fast Delivery” technology company and we provide E-Commerce delivery solutions. We serve “Next-Day”, "Same-Day" and "3 Hours Express" deliveries to e-commerce companies. In addition to it, we form “Private Dedicated Field Delivery Teams” to companies as a special delivery team of brand. Wedigitalize all the delivery process by our unique software and technology.Focus on the job which you are best at! Rest, all your packages will be delivered by PackUpp, Fast Delivery Expert.
- Salty Enerji — Salty Enerji is a manufacturing company that designs energy storage infrastructure to enhance renewable power efficiency and distribution.
- Weddingbouquet.com — DüğünBuketi is a web and special event organization portal that brings wedding firms together to get price quotes. It was founded in 2017 and is based in Izmir, Turkey.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 75
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 576
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- resTORbio — Restore Beauty - Rethink Bio
- Caris Life Sciences — Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $270M in 2021
Portfolio highlights
- Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1M–$7M; Series A $4M–$6M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 49
- Round size: Seed $439k–$2.7M; Series A $985k–$2.5M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $32M in 2020
Portfolio highlights
- Boby.ai — Boby.ai develops artificial intelligence-supported mobile applications for end users
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- PowerDev — PowerDev allows renewable energy contenders to make decisive and sustainable battery storage and green hydrogen investments.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 68
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Invest in groundbreaking startups with iAngels. Discovercutting-edge technology and join a community of forward-thinking investors shapingthe future of entrepreneurship.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Seed, Series A
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 120
- Round size: Seed $1M–$10M; Series A $4.5M–$22M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $56M in 2021
Portfolio highlights
- Nas Daily —
- Wild Moose — Wild Moose helps on-call developers more quickly identify the source of production incidents, by providing a conversational AI trained on their environment. This allows developers to delegate the search through logs and metrics to lightning-fast AI.
- Lava Network — Lava Network aims to be a marketplace for blockchain data.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $1.3M–$5M; Series A $10M–$40M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 118
- Round size: Seed $1.5M–$7M; Series A $3M–$20M; Series B $2.5M–$53M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Fathom Therapeutics — Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic molecules through computational drug discovery approaches. The company develops models that simulate biomolecular and protein motion to better understand how proteins behave and interact, enabling the identification of new therapeuticstrategies. Its platform combines generative design, predictive modeling, and computational assays to create and evaluate molecular candidates for their binding affinity and functional effects. By leveraging these simulations, it supports drug discovery processes such as hit identification, lead optimization, and the design of targeted molecules, including degraders and molecular glues. The company also collaborates with partners by providing molecular designs, predictive insights, and co-development opportunities for advancing therapeutic candidates.
- Adro — Designed to work when you arrive Spend and save like a local. Easy to use. No unfair fees.
- CREW Carbon — CREW provides wastewater treatment facilities with a process intensification solution that improves performance, lowers costs, and permanently removes greenhouse gasses.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 103
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.
Show more...Investment focus
- Industry: mHealth, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Israel, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.9M–$19M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
- Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
ISTcapital is a family office-backed venture capital firm partnering with exceptional founders to build early-stage, global technology companies.
Show more...Investment focus
- Industry: Biotechnology, Beauty, Gaming
- Stage:Seed, Series A
- Geography: Turkey, United States
Investor stats
- Total investments: 7
- Round size: Seed $1M–$2.5M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Cellestetix — Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness.
- Spline — Spline is a free 3D design software with real-time collaboration to create web interactive experiences in the browser. Easy 3d modeling, animation, textures, and more.
- PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Nutrition
- Stage:Pre-Seed, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 4
- Round size: Pre-Seed $1.8M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $1.7M–$4.1M; Series A $1M–$10M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- MEDX Xelerator — MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.
- Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United Kingdom, Estonia
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Cyber Security, Health Care
- Stage:Seed, Series B, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more...Investment focus
- Industry: Software, Information Technology, Computer
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, France, United States
Investor stats
- Total investments: 14
- Round size: Series A $8M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Rookout — Code doesn’t always behave as you expect it to and your team is wasting too much time to understand why. Rookout provides secure, fast, and simple data access, no matter what architecture or where the code is running. By providing the developer with instant, laser-focused data, developer teams can understand their code and see an increase inproductivity, velocity, and efficiency.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink Technologies is developing a robust, non-intrusive passive, eye-tracking technology without the need for special dedicated hardware. Their non-invasive, AI-based Software Solution can be deployed with any Camera technology on the market today. The proprietary solution integrates with any OS and can run locally (edge-based) or remotely(cloud-based).Blink Technologies was founded in 2018 and is based in Palo Alto, California, United States.
EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Grant, Seed
- Geography: United Kingdom, Israel, Germany
Investor stats
- Total investments: 87
- Round size: Seed $226k–$11M; Grant $30k–$572k
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- BettaF!sh — BettaF!sh is the first company developing 100% plant-based tuna alternatives mainly created with seaweed from Europe.
- Ficosterra — fertilizers and bio-fertilizers, 100% vegetable and ecological, with algae and microorganisms that favor the maximum development of crops and plants.
- Hooked Foods — Leading the transition to a harmless seafood system by serving healthy vegan seafood for everybody to truly enjoy.
Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.
Show more...Investment focus
- Industry: Food and Beverage, Manufacturing, Retail
- Stage:Seed, Series A, Convertible Note
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $2.5M–$4.1M; Series A $3.5M–$15M; Convertible Note $4M–$10M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- ansā — Objectively Awesome Coffee
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 277
- Round size: Series A $4M–$47M; Series B $7.5M–$44M; Series C $8.2M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $175M in 2023
Portfolio highlights
- Nexite — Nexite develops a platform that provides item tracking, inventory transparency and business intelligence from manufacturing to the customer's home. Its miniature NanoBT batteryless tag can be read by any smartphone, costs a fraction of the cost of similar tags, and is small enough to embed into the item. The company was founded in 2017 andis headquartered in Tel Aviv, Israel.
- Sayata — Sayata delivers rapid growth to brokers and carriers that place commercial risk.The Sayata platform streamlines the quote-bind-issue process allowing insurance professionals to seamlessly place commercial risk in a fraction of the time.Sayata provides an end-to-end technological solution along with educational tools, giving our partners theability to grow their book quickly and efficiently.To date, over 1,000 users across 75 brokerages and carriers partner with Sayata to grow their commercial book.
- Topspin Medical — TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturizedto less than 2 millimeters in size.
NevaTeam Partners is an Agri-Food Tech ESG Impact driven Fund with world-class knowledge and expertise that specializes in identifying and investing in cutting-edge companies and technologies, contributing to the streamlining and increase in world food production in a sustainable way.
Show more...Investment focus
- Industry: AgTech, SaaS, Farming
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 5
- Round size: Seed $5M–$10M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- Clarifruit — First automated fruit and vegetable fresh produce quality control software solution by Clarifresh. Optimize your fresh produce QC >>
- Edete Precision Technologies for Agriculture — edete Precision Agriculture Technologies is solving the world’s ever-growing pollination challenge by developing and manufacturing an efficient, automated fruit orchard pollination system and providing optimized pollination services to companies and growers.By reducing the dependency on haphazard, insect-based pollination processes, edete’scontrolled and manageable mechanical pollination system improves the quantity and quality of fruit orchard yields.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
Show more...Investment focus
- Industry: Pharmaceutical, Cannabis, Biopharma
- Stage:Corporate Round
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Corporate Round $400k–$700k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
- MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Egypt, Ireland, United States
Investor stats
- Total investments: 23
- Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Educatly — Educatly is a Life Direction Intelligence Platform helping people discover their passions, explore careers, and design the learning paths that shape their future.
- D OCC Hub — Smart Incident Management Solutions
- InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 10
- Round size: Series A $5.4M–$28M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $50M in 2019
Portfolio highlights
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
- Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Nutrition
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 55
- Round size: Seed $1.7M–$6.3M; Series A $5M–$21M; Series B $10M–$106M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Exosomm — Exosomm is an advanced BioTech-FoodTech startup, located in Israel, that created a food formula for medical purposes, containing patent-based milk exosomes for patients with inflammatory bowel diseases (IBD).
- BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Biopharma
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Hardware
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 4
- Round size: Seed $500k–$1M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Sqwik - powered by Geev.Me.Tech LTD — Sqwik is a new way to create, join & follow fun activities, with new friends, within 3 hours.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
Kinisis Ventures is a venture capital firm backing bold founders building the future. Discover our portfolio, meet our team, and explore how we support startups from seed to scale.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Internet of Things
- Stage:Seed, Series A
- Geography: Cyprus, United States, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $1.1M–$2M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Darefore — Darefore is a technologically advanced brand that has revolutionized cycling performance with a clever position sensor.
- Threedium — Threedium is a 3D engine. We believe that democratizing the creation and distribution of 3D and AR experiences represents our greatest opportunity to improve the way people buy and sell products.
- Smartline — The world's most elegant health companion
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 41
- Round size: Seed $3M–$12M; Pre-Seed $120k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Clearitty — Clearitty - The Ultimate Sales Accelerator by Turning Deal Insights into Revenue We provide the tools and insights for sales executives to close deals faster and outperform competitors, empowering you to drive growth and success. It’s free to start — no trial, no contract, no risk.Clearitty was born out of a shared frustration experienced bysales executives and entrepreneurs alike – the lack of critical insights about new buyers. These invaluable insights are often held by those who have successfully navigated the sales process with these coveted clients.Recognizing the gap, in 2022 we created Clearitty, dedicated to developing an intelligence tool that helps sales executives shorten sales cycles and close deals more efficiently.Our goal is to build the world’s largest database of buyer insights, empowering sales executives with the knowledge they need to succeed.
- Sherloq — Ask your SQL anything. Built on your context, directly on your editor.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 36
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- NeuroPace — The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
- UltraClear —
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Early stage deep tech investor
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Convertible Note
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $345k–$3.2M; Series A $2.4M–$9M; Convertible Note $987k–$1.3M
- Lead/follow: 74% lead, 26% follow
- Last fund: May invest from a new fund soon — raised $29M in 2015
Portfolio highlights
- Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
- Rototip — On demand CNC manufacturing Rototip Milling Turning Bespoke Manufacturing
- Picus — The Complete Security Control Validation Platform | Stay proactive by validating your security controls with attack scenarios, empower your Red, Purple, Blue teams.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Series B, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 88
- Lead/follow: no public data
Portfolio highlights
- V-Wave — V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
- ShopperAI — AI-powered shelf monitoring using your existing security cameras
- Exceed Talent Capital — Exceed is an innovative platform to invest, earn, engage, influence, and celebrate Talent.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Lead/follow: no public data
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.
Show more...Investment focus
- Industry: Software, Machine Learning, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Cybord — Electronics components' quality, reliability, and highest level of traceability by leveraging visual AI and BigData
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Nigeria, Egypt
Investor stats
- Total investments: 111
- Lead/follow: no public data
Portfolio highlights
- Craydel — Get Professional career guidance based on Psychometric Assessments and get scholarships to the best MBA, Engineering, Medical, Education online and on campus courses in Africa and Abroad.
- EMTECH — For Modern Central Banking
- Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.
Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.
Show more...Investment focus
- Industry: Wellness, Biotechnology, Manufacturing
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- SolCold — We make the sun cool again - Solcold the new environment solutions
- Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!